Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/14/2003CN1108291C Method for preparing substituted perhydroisoindole
05/14/2003CN1108159C Traditional Chinese medicine for curing diabetes and kidney deficiency
05/14/2003CN1108150C Method and composition for increasing calcium uptake
05/13/2003US6562984 Mixing with surfactants and detergent; purification by ion exchanging
05/13/2003US6562976 Such as methyl-2-cyclopentyl-4-(4-fluorophenyl)-5-oxo-7,7-dimethyl-1,4,5,6,7,8 -hexahydroquinoline-3-carboxylate for treatment of arteriosclerosis and dyslipidaemias; condensation
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562866 A method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin or a mixture thereof.
05/13/2003US6562862 Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
05/13/2003US6562860 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562836 Islet amyloid polypeptide (IAPP) is known to be capable of forming fibrils which are deposited in the pancreas of patients wtih type II diabetes
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562814 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003US6562329 Administering lipase inhibitors
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037905A1 Silicon compounds
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037881A1 α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037864A1 Indole compound and medicinal use thereof
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037316A1 Peroxisome proliferator activated receptor ligands and process for producing the same
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002064129A3 Compositions of biochemical compounds involved in bioenergy metabolism of cells
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087941 Administering a dopamine D1, D2, D3, and D4 receptor agonist such as pramipexole or talipexole.
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087907 Quinoline derivatives and quinazoline derivatives having azolyl group
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders.
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087883 Therapeutic 5-HT ligand compounds
05/08/2003US20030087876 Amino derivative of a disaccharide and an oxidized disaccharide or a derivative
05/08/2003US20030087873 Treating a Flaviviridae, Orthomyxoviridae or Paramyxoviridae infection
05/08/2003US20030087868 Administration of a vector to cells in vivo comprising and expressing a transgene encoding beta-glucosidase, the vector is taken up by the cells, the transgene is expressed therein and and beta-glucosidase is produced
05/08/2003US20030087841 Disaccharide derivatives for treating hyperglycaemia
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087821 Using exendrin, or antagonist thereof; appetite control
05/08/2003US20030087820 Novel exendin agonist formulations and methods of administration thereof
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
1 ... 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 ... 1298